Celecoxib Synergistically Enhances MLN4924-Induced Cytotoxicity and EMT Inhibition Via AKT and ERK Pathways in Human Urothelial Carcinoma

Cancer statistics, 2020

(2020) Rebecca L. Siegel et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Targeting Cullin-RING E3 Ligases for Radiosensitization: From NEDDylation Inhibition to PROTACs

(2020) Shuhua Zheng et al.   Frontiers in Oncology

Neddylation: a novel modulator of the tumor microenvironment

(2019) Lisha Zhou et al.   Molecular Cancer

Akt in cancer: Mediator and more

(2019) Sundaramoorthy Revathidevi et al.   SEMINARS IN CANCER BIOLOGY

Role of AKT and mTOR signaling pathways in the induction of epithelial-mesenchymal transition (EMT) process

(2019) Mostafa Karimi Roshan et al.   BIOCHIMIE

Epithelial Mesenchymal Transition in Tumor Metastasis

(2018) Vivek Mittal   Annual Review of Pathology-Mechanisms of Disease

Protein neddylation and its alterations in human cancers for targeted therapy

(2018) Lisha Zhou et al.   CELLULAR SIGNALLING

Ubiquitination: Friend and foe in cancer

(2018) Mohammed A. Mansour   INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY

Cyclooxygenase inhibitors potentiate receptor tyrosine kinase therapies in bladder cancer cells in vitro

(2018) Jennifer Bourn et al.   Drug Design Development and Therapy

Celecoxib in Cancer Therapy and Prevention – Review

(2018) Natalia Tolloczko - Iwaniuk et al.   CURRENT DRUG TARGETS

CCL17-CCR4 axis promotes metastasis via ERK/MMP13 pathway in bladder cancer

(2018) Hongda Zhao et al.   JOURNAL OF CELLULAR BIOCHEMISTRY

Celecoxib alleviates AKT/c-Met-triggered rapid hepatocarcinogenesis by suppressing a novel COX-2/AKT/FASN cascade

(2018) Zhenpeng Qiu et al.   MOLECULAR CARCINOGENESIS

The PI3K/AKT Pathway as a Target for Cancer Treatment

(2016) Ingrid A. Mayer et al.   Annual Review of Medicine

Management of non-muscle invasive bladder cancer: A comprehensive analysis of guidelines from the United States, Europe and Asia

(2016) Wei Shen Tan et al.   CANCER TREATMENT REVIEWS

Expanding the Ubiquitin Code

(2016) Krishnaraj Rajalingam et al.   CELL

Blockage of neddylation modification stimulates tumor sphere formation in vitro and stem cell differentiation and wound healing in vivo

(2016) Xiaochen Zhou et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

MLN4924, a novel protein neddylation inhibitor, suppresses proliferation and migration of human urothelial carcinoma: In vitro and in vivo studies

(2015) Kuan-Lin Kuo et al.   CANCER LETTERS

Drug Combination Studies and Their Synergy Quantification Using the Chou–Talalay Method—Letter

(2015) John C. Ashton   CANCER RESEARCH

Targeting ubiquitination for cancer therapies

(2015) John Kenneth Morrow et al.   Future Medicinal Chemistry

CXCL5/CXCR2 axis promotes bladder cancer cell migration and invasion by activating PI3K/AKT-induced upregulation of MMP2/MMP9

(2015) YE GAO et al.   INTERNATIONAL JOURNAL OF ONCOLOGY

Signaling pathway of MAPK/ERK in cell proliferation, differentiation, migration, senescence and apoptosis

(2015) Yu Sun et al.   JOURNAL OF RECEPTORS AND SIGNAL TRANSDUCTION

Inhibition of epithelial-mesenchymal transition in bladder cancer cells via modulation of mTOR signalling

(2015) Banu Iskender et al.   TUMOR BIOLOGY

MLN4924 Synergistically Enhances Cisplatin-induced Cytotoxicity via JNK and Bcl-xL Pathways in Human Urothelial Carcinoma

(2015) I-Lin Ho et al.   Scientific Reports

Targeting Neddylation Pathways to Inactivate Cullin-RING Ligases for Anticancer Therapy

(2014) Yongchao Zhao et al.   ANTIOXIDANTS & REDOX SIGNALING

Comprehensive molecular characterization of urothelial bladder carcinoma

(2014)   NATURE

Cyclooxygenase-2 Expression in Urinary Bladder Transitional Cell Carcinoma and its Association with Clinicopathological Characteristics

(2013) Hedieh Moradi Tabriz et al.   Asian Pacific Journal of Cancer Prevention

COX-2 inhibitors block chemotherapeutic agent-induced apoptosis prior to commitment in hematopoietic cancer cells

(2011) Claudia Cerella et al.   BIOCHEMICAL PHARMACOLOGY

A turbulent decade for NSAIDs: update on current concepts of classification, epidemiology, comparative efficacy, and toxicity

(2011) Philip G. Conaghan   RHEUMATOLOGY INTERNATIONAL

Substrate-Assisted Inhibition of Ubiquitin-like Protein-Activating Enzymes: The NEDD8 E1 Inhibitor MLN4924 Forms a NEDD8-AMP Mimetic In Situ

(2010) James E. Brownell et al.   MOLECULAR CELL

mTOR signaling at a glance

(2009) M. Laplante et al.   JOURNAL OF CELL SCIENCE

An inhibitor of NEDD8-activating enzyme as a new approach to treat cancer

(2009) Teresa A. Soucy et al.   NATURE

Novel substrates and functions for the ubiquitin-like molecule NEDD8: Figure 1

(2008) Dimitris P. Xirodimas   BIOCHEMICAL SOCIETY TRANSACTIONS

Proteasome Inhibitors in Cancer Therapy: Lessons from the First Decade

(2008) R. Z. Orlowski et al.   CLINICAL CANCER RESEARCH